Robin Campbell

Robin Campbell

Plus aucun poste en cours

Finance
Health Technology
Consumer Services

Profil

Dr. Robin Campbell is an Analyst at Equity Development Ltd., a Chairman at HemoGenyx Pharmaceuticals Plc and a Chief Investment Officer at NetScientific Plc.
Dr. Campbell has over 30 years of experience working with large companies.
Currently, his specialty is searching out investable opportunities in the broader life sciences sector, and helping small companies raise growth capital.
Dr. Campbell has helped list a number of companies onto the AIM and international exchanges, advised companies on secondary fundraisings, private equity raises, M&A and has a broad reach into institutional and retail investor networks.
Dr. Campbell was previously employed as a Research Analyst by Cantor Fitzgerald Europe, by Seymour Pierce Ltd., by ING Bank NV (United Kingdom), and by Jefferies International Ltd.
(Old).
He also worked as Head of Life Sciences by Merchant Securities Ltd., a Global Head of Healthcare Research by Religare Capital Markets Plc, and an Analyst by ABN AMRO Hoare Govett and by WestLB Panmure Ltd.
Dr. Campbell also worked at Credit Suisse Securities (Europe) Ltd., at GlaxoSmithKline Plc, and at Paribas Capital Markets.
He received his undergraduate degree from the University of London, a degree in Microbiology from King's College London and a PhD in Immunobiology from The University of Liverpool.

Anciens postes connus de Robin Campbell

SociétésPosteFin
HEMOGENYX PHARMACEUTICALS PLC Président 03/04/2018
Analyst-Equity 01/03/2013
Analyst-Equity 01/02/2013
Analyst-Equity 01/10/2012
Religare Capital Markets (Europe) Ltd. Directeur de la Recherche - Actions 15/11/2010
Voir l'expérience en détail de Robin Campbell

Formation de Robin Campbell

The University of Liverpool Doctorate Degree
University of London Undergraduate Degree
King's College London Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Robin Campbell

Relations

36

Relations au 1er degré

17

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
GSK PLC

Health Technology

NETSCIENTIFIC PLC

Health Technology

HEMOGENYX PHARMACEUTICALS PLC

Health Technology

Entreprise privées11
Jefferies International Ltd. (Old)

Finance

Religare Capital Markets (Europe) Ltd.

Finance

ING Bank NV (United Kingdom)

Finance

Finance

WestLB Panmure Ltd.

Finance

ABN AMRO Hoare Govett

Finance

Paribas Capital Markets

Finance

Finance

Finance

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Robin Campbell